
|Articles|February 11, 2020
Eversana Reveals New Portfolio of Consulting Services
Advertisement
Eversana, an independent provider of commercial services to the life sciences industry, revealed Eversana Consulting, its new global consulting services focused on the pharma and biotech industries. Eversana Consulting was created to address challenges across the product lifecycle.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Thermo Fisher Enters $8.8 Billion Definitive Agreement to Acquire Clario Holdings
2
Lilly Forms Partnership with NVIDIA to Create AI Supercomputer
3
FDA Announces New Biosimilar-Targeted Draft Guidance
4
Investors Have Questions About GLP-1 Drug Prices Ahead of Eli Lilly and Novo Quarterly Statements: Report
5





